These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3959321)

  • 1. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.
    Csuka M; Carrera GF; McCarty DJ
    JAMA; 1986 May; 255(17):2315-9. PubMed ID: 3959321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.
    McCarty DJ; Carrera GF
    JAMA; 1982 Oct; 248(14):1718-23. PubMed ID: 6750154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.
    Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B
    Br Med J; 1974 Sep; 3(5934):763-6. PubMed ID: 4606370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term treatment of rheumatoid arthritis with azathioprine and cyclophosphamide].
    Fricke R; Deicher H
    Verh Dtsch Ges Rheumatol; 1969; 1():394-401. PubMed ID: 4997351
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters.
    Bell CL
    Am J Med; 1983 Jul; 75(1A):46-51. PubMed ID: 6346870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.
    Tett SE; Day RO; Cutler DJ
    J Rheumatol; 1993 Nov; 20(11):1874-9. PubMed ID: 8308772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intractable RA--treatment with combined methotrexate, azathioprine and hydroxychloroquine.
    Langevitz P; Kaplinsky N; Ehrenfeld M; Pras M
    Br J Rheumatol; 1989 Jun; 28(3):271-2. PubMed ID: 2730992
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled trial of cyclophosphamide in rheumatoid arthritis.
    Cooperating Clinics Committee of the American Rheumatism Association
    N Engl J Med; 1970 Oct; 283(17):883-9. PubMed ID: 4917724
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheumatoid arthritis.
    Emery P; Suarez-Almazor M
    Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 15. Azathioprine and cyclophosphamide as slow-acting drugs for rheumatoid arthritis.
    Decker JL
    Am J Med; 1983 Dec; 75(6A):74-8. PubMed ID: 6660242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.
    Porter DR; Capell HA; Hunter J
    J Rheumatol; 1993 Apr; 20(4):645-9. PubMed ID: 8496858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effectiveness and combined administration of basic drugs in rheumatoid arthritis].
    Noskov SM; Kozlov GS
    Revmatologiia (Mosk); 1991; (1):26-9. PubMed ID: 1676853
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents.
    Seidenfeld AM; Smythe HA; Ogryzlo MA; Urowitz MB; Dotten DA
    J Rheumatol; 1976 Sep; 3(3):295-304. PubMed ID: 978665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of cyclophosphamide in rheumatoid arthritis.
    Townes AS; Sowa JM; Shulman LE
    Arthritis Rheum; 1976; 19(3):563-73. PubMed ID: 779796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.
    Paulus HE
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):26-9. PubMed ID: 7065739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.